California State Teachers Retirement System (CalSTRS)’s Elevation Oncology ELEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,780
Closed -$979 3026
2025
Q1
$979 Hold
3,780
﹤0.01% 3041
2024
Q4
$2.13K Hold
3,780
﹤0.01% 3046
2024
Q3
$2.27K Hold
3,780
﹤0.01% 3050
2024
Q2
$10.2K Buy
+3,780
New +$14.2K ﹤0.01% 2894

Other funds holding ELEV

California State Teachers Retirement System (CalSTRS)'s ELEV Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Elevation Oncology (ELEV) in Q2 2025, closing a stake of 3,780 shares — an estimated $979 sold.

California State Teachers Retirement System (CalSTRS) first reported a position in ELEV in Q2 2024 and held it in 4 quarters. The position peaked at $10.2K in Q2 2024. 65 funds tracked by Wall St. Rank hold ELEV as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Elevation Oncology position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 3,780 Elevation Oncology shares in Q2 2025, an estimated $979.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Elevation Oncology in Q2 2024 and held it in 4 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Elevation Oncology position peaked at $10.2K in Q2 2024.
  • 65 funds tracked by Wall St. Rank held Elevation Oncology as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.